Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/GILD
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Gilead Sciences, Inc. (GILD) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Gilead Sciences (GILD) trades at $134.32, up 2.91% today, with a bullish technical signal from moving averages and strong profitability metrics including a 30.99% net income margin. Recent earnings beats in Q3 2025, Q4 2025, and Q1 2026 highlight operational strength, while Q2 2026 faces an expected loss. The company maintains robust cash flow from operations of $10.02B in 2025 and benefits from positive developments in its HIV and oncology pipelines, such as the CHMP recommendation for Trodelvy in July 2026.
The outlook for GILD is positive, supported by analyst consensus with a $148.50 price target and 65.52% buy ratings. Key opportunities include growth in HIV treatments and oncology progress, but risks involve competitive pressures in cell therapy and potential earnings volatility. The stock's current valuation at a P/E of 18.06 offers a reasonable entry point for investors seeking exposure to a stable biopharmaceutical leader.
Read full analysis

Key Stats

  • Market Cap
    $164.79B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $155.80
  • 52W Low
    $110.28
  • Typical Hold Time
    -
  • Enterprise Value
    $179.32B
  • Div Yield
    2.47%
  • Trading Activity
    -
$130.36
52W Low: $110.28
07 Aug 2025
52W High: $155.8
11 Feb 2026

Track Gilead Sciences, Inc. (GILD) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Gilead Sciences, Inc. has traded between a low of $110.28 and a high of $155.8, highlighting its annual price range. Buy and sell Gilead Sciences, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Gilead Sciences, Inc.

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.

Most Recent News

Content is generated by Aura AI

UBS Group AG holds 4% stake in Bang & Olufsen as of July 27, 2026, below 5% threshold.

UBS Group AG has reported holding 5,898,317 shares in Bang & Olufsen A/S, representing 4.00% of the company's total share capital and voting rights as of July 27, 2026. This disclosure is made under the Danish Capital Markets Act, indicating UBS's st...

Market News
1 hour ago
Na
Neutral
pluang ai news

BP plans to sell its North Sea business to focus on higher-return assets under new CEO.

BP has initiated the sale of its North Sea business as part of a strategic move by new CEO Meg O'Neill to simplify the company's portfolio and prioritize investments in higher-return opportunities. While the North Sea remains vital to the UK's energy...

Market News
4 hours ago
Proactive Investors
Neutral
pluang ai news

Over 120,000 Galanz refrigerators recalled due to fire risk after 34 fire reports, including one death.

The U.S. Consumer Product Safety Commission announced a recall of about 121,680 Galanz Retro Refrigerators due to fire and burn hazards. The refrigerators, sold from January 2019 to September 2022 at Home Depot and Amazon, have internal electrical co...

Market News
4 hours ago
Fox Business
Bearish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $164.79B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $155.80
  • 52W Low
    $110.28
  • Typical Hold Time
    -
  • Enterprise Value
    $179.32B
  • Div Yield
    2.47%
  • Trading Activity
    -
$130.36
52W Low: $110.28
07 Aug 2025
52W High: $155.8
11 Feb 2026

Track Gilead Sciences, Inc. (GILD) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Gilead Sciences, Inc. has traded between a low of $110.28 and a high of $155.8, highlighting its annual price range. Buy and sell Gilead Sciences, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!